SEOUL (Reuters) – Five South Korean companies have launched clinical trials for their coronavirus vaccines, aiming to enter the third phase of trials in the second half of this year, the Yonhap news agency reported on Monday, citing health authorities.
(Reporting by Hyonhee Shin; Editing by Catherine Evans)
